Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroactive steroids and affective disorders.

D Eser1, C Schüle, T C Baghai

  • 1Department of Psychiatry, Ludwig-Maximilian-University, Nussbaumstr. 7, 80336 Munich, Germany.

Pharmacology, Biochemistry, and Behavior
|July 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Assessment of university psychiatry and psychotherapy in Germany: Responsibilities and challenges : Position paper of the Lehrstuhlinhaber für Psychiatrie und Psychotherapie e. V. (LIPPs) in Germany].

Der Nervenarzt·2024
Same author

Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [<sup>18</sup>F]FET PET, and TSPO PET.

European journal of nuclear medicine and molecular imaging·2024
Same author

What are the consequences of cancer on the return to work among French military personnel?

BMJ military health·2023
Same author

Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Beta-blockers in pulmonary arterial hypertension: Time for a second thought?

Vascular pharmacology·2022
Same author

Use of Narrow-Diameter Implants in Completely Edentulous Patients as a Prosthetic Option: A Systematic Review of the Literature.

BioMed research international·2021
Same journal

Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.

Pharmacology, biochemistry, and behavior·2026
Same journal

Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains.

Pharmacology, biochemistry, and behavior·2026
Same journal

Spontaneous oxycodone withdrawal alters behavior and oligodendrocyte-related gene expression in mice.

Pharmacology, biochemistry, and behavior·2026
Same journal

Improvement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study.

Pharmacology, biochemistry, and behavior·2026
Same journal

Long-term follow-up of children with autism spectrum disorder and severe treatment-resistant behavioral symptoms treated with purified cannabidiol.

Pharmacology, biochemistry, and behavior·2026
Same journal

Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease.

Pharmacology, biochemistry, and behavior·2026
See all related articles

Neuroactive steroids, like GABA(A) receptor modulators, are implicated in depression and anxiety. Their levels change in these disorders, and antidepressant drugs may alter them, suggesting therapeutic potential.

Area of Science:

  • Neuroendocrinology
  • Psychopharmacology
  • Neurobiology

Background:

  • Neuroactive steroids modulate neurotransmission via receptors like GABA(A).
  • Preclinical data links neuroactive steroids to anxiety and depression behaviors.
  • Reduced neuroactive steroid levels are observed in major depression and anxiety disorders.

Purpose of the Study:

  • To investigate the role of neuroactive steroids in psychiatric conditions.
  • To explore the impact of antidepressant treatments on neuroactive steroid composition.
  • To assess the potential of neuroactive steroids as therapeutic agents for affective disorders.

Main Methods:

  • Analysis of neuroactive steroid composition in patients with psychiatric disorders.
  • Observation of neuroactive steroid level changes following antidepressant pharmacotherapy.

Related Experiment Videos

  • Review of preclinical and clinical studies on neuroactive steroids and affective disorders.

    • Main Results:

    • Dysequilibrium of neuroactive steroids observed in panic disorder patients.
    • Alterations in 3alpha-reduced pregnane steroids during depression corrected by antidepressant treatment.
    • Changes in neuroactive steroids post-mirtazapine therapy appear independent of clinical response, suggesting direct pharmacological effects.

    Conclusions:

    • Neuroactive steroids play a significant role in modulating depression and anxiety.
    • Antidepressant pharmacotherapy may influence neuroactive steroid composition, potentially alleviating symptoms like anxiety and sleep disturbances.
    • Neuroactive steroids offer a promising basis for developing novel treatments for affective disorders.